These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 5854537)

  • 1. [A prolonged-action oxacillin].
    Lazareva EN; Bishara EI
    Antibiotiki; 1965 Jun; 10(6):492-6. PubMed ID: 5854537
    [No Abstract]   [Full Text] [Related]  

  • 2. [A comparative cytochemical study on the effect of penicillin, its delayed-action preparations and oxacillin on tissue culture cells].
    Scherbakova EG
    Antibiotiki; 1966 Apr; 11(4):337-43. PubMed ID: 5984184
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of oxacillin- and multidrug-resistant staphylococci in clinical samples from dogs: 1,772 samples (2001-2005).
    Jones RD; Kania SA; Rohrbach BW; Frank LA; Bemis DA
    J Am Vet Med Assoc; 2007 Jan; 230(2):221-7. PubMed ID: 17223755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro control of pharmaceutical preparations with delayed action].
    Norby P
    Dan Tidsskr Farm; 1965 May; 39(5):171-85. PubMed ID: 5839227
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of tests to detect oxacillin resistance in Staphylococcus intermedius, Staphylococcus schleiferi, and Staphylococcus aureus isolates from canine hosts.
    Bemis DA; Jones RD; Hiatt LE; Ofori ED; Rohrbach BW; Frank LA; Kania SA
    J Clin Microbiol; 2006 Sep; 44(9):3374-6. PubMed ID: 16954277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and genotypic characteristics of methicillin/oxacillin-resistant Staphylococcus intermedius isolated from clinical specimens during routine veterinary microbiological examinations.
    Zubeir IE; Kanbar T; Alber J; Lämmler C; Akineden O; Weiss R; Zschöck M
    Vet Microbiol; 2007 Mar; 121(1-2):170-6. PubMed ID: 17174042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect maternal effects of oxacillin administered to pregnant mice on the postnatal immune response of the offspring.
    Dostál M; Horká I; Tůma O; Soukupová D
    Funct Dev Morphol; 1994; 4(2):67-75. PubMed ID: 7873801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on the stabilization of drugs in solution. 3. A chemical kinetic study of oxacillin in aqueous solution].
    Hsi NC; Chao FS; Feng YS
    Yao Xue Xue Bao; 1965 Sep; 12(9):615-22. PubMed ID: 5899045
    [No Abstract]   [Full Text] [Related]  

  • 9. [Research on the anticholinergic action of some belladonna products with prolonged action].
    Winter D; Sauvard S; Stănescu C; Enescu L
    Stud Cercet Fiziol; 1966; 11(1):69-72. PubMed ID: 5940046
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination between fosfomycin and oxacillin or cefotaxime against methicillin-resistant Staphylococci and Enterococci].
    Duez JM; Kohli E; Pechinot A; Tremeaux JC; Kazmierczak A
    Pathol Biol (Paris); 1983 Jun; 31(6):515-8. PubMed ID: 6308543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DRUGS WITH PROLONGED ACTION].
    TEOTINO UM
    Farmaco Prat; 1964 Aug; 19():357-65. PubMed ID: 14177538
    [No Abstract]   [Full Text] [Related]  

  • 12. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Current status of recommendations for treatment with an APAP].
    Buis C; Gourion D; Vaiva G
    Encephale; 2009 Jan; Suppl 3():S91-5. PubMed ID: 19268185
    [No Abstract]   [Full Text] [Related]  

  • 13. Narcotic antagonists: naltrexone pharmacochemistry and sustained-release preparations.
    NIDA Res Monogr; 1981; 28():1-273. PubMed ID: 6790998
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral sustained-release products: pro's and con's.
    Drug Ther Bull; 1984 Jul; 22(15):57-60. PubMed ID: 6468281
    [No Abstract]   [Full Text] [Related]  

  • 15. [Relation between the structure of polymers and the controlled release of active ingredients].
    Peppas NA; Gurny R
    Pharm Acta Helv; 1983; 58(1):2-8. PubMed ID: 6338530
    [No Abstract]   [Full Text] [Related]  

  • 16. Cefoxitin disk diffusion screen for confirmation of oxacillin-resistant Staphylococcus aureus isolates and utility in the clinical laboratory.
    Sharp SE; Warren JA; Thomson RB
    Diagn Microbiol Infect Dis; 2005 Jan; 51(1):69-71. PubMed ID: 15629232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticomplement effect of oxacillin in vitro and in vivo].
    Shirova L; Toshkov A; Musaeva A
    Acta Microbiol Bulg; 1982; 11():94-8. PubMed ID: 7171043
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antilysin with a prolonged effect in dogs with experimental acute pancreatitis].
    Bartos V; Kolc J; Vanĕcek R; Saudek V; Drobník J; Havranová M; Cechová D
    Cesk Gastroenterol Vyz; 1983 Apr; 37(3):170-5. PubMed ID: 6191876
    [No Abstract]   [Full Text] [Related]  

  • 19. Controlled release from microcapsules.
    Traisnel MM
    Boll Chim Farm; 1984 Jul; 123(7):303-12. PubMed ID: 6518088
    [No Abstract]   [Full Text] [Related]  

  • 20. Conception of peroral sustained-release dosage forms: calculation of initial and maintenance dose with consideration of accumulation.
    Förster H; Lippold BC
    Pharm Acta Helv; 1982; 57(12):345-9. PubMed ID: 7156173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.